Anti-CD19 antibody drug conjugates
ZA202409513BActive Publication Date: 2026-07-29ABBVIE BIOTHERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- ZA202409513
- Authority / Receiving Office
- ZA · ZA
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2023-06-15
- Filing Date
- 2024-12-10
- Publication Date
- 2026-07-29
- Estimated Expiration
- 2044-12-10
Abstract
The present disclosure provides anti-CD19 antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.
Need to check novelty before this filing date? Find Prior Art